A new high-accuracy low-cost infusion pump has attracted £250,000 funding from The Capital Fund, a £50 million venture capital fund that invests in fast-growth companies in Greater London.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.